Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

12.9x

Market Cap

CNY 2.75B

MomentumView details →

1D Return

−2.47%

YTD Return

−0.80%

RSI (14)

54.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

12.9x

Market Cap

CNY 2.75B

RSI (14)

54.9

MomentumView details →

1D Return

−2.47%

YTD Return

−0.80%

ProfitabilityView details →

Gross Margin

18.48%

Net Margin

2.62%

EBITDA Margin

6.98%

ROE (TTM)

4.51%

ROA (TTM)

1.83%

Asset Turnover

0.72x

GrowthView details →

Revenue YoY

−8.56%

EPS YoY

−35.22%

FCF YoY

+48.32%

Revenue CAGR 3Y

−1.23%

EPS CAGR 3Y

−23.98%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.43x

Current Ratio

0.90x

Quick Ratio

0.67x

Div Yield

1.61%

Div Rate

CNY 0.10

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

3.75B

Net Income (TTM)

98.40M

Op. CF (TTM)

116.27M

Latest newsMore news →

Fengyuan Pharmaceutical's wholly-owned subsidiary Bengbu Fengyuan Tushan Pharmaceutical received drug registration certificates from China's National Medical Products Administration for vonoprazan fumarate tablets (20mg and 10mg).6d ago

Fengyuan Pharmaceutical announced that its controlling shareholder Fengyuan Group's concert parties (Anhui Wuwei Pharmaceutical Factory, Ma'anshan Fengyuan Enterprise Management, and Bengbu Tushan Enterprise Management) signed a share transfer agreement with Bengbu Investment Group to transfer 100 million shares (21.53% of total shares) for 641 million yuan, which will change the controlling shareholder to Bengbu Investment Group and the actual controller to Bengbu State-owned Assets Supervision and Administration Commission.20d ago

Similar companies

久盛电气301082.SZ 天秦装备300922.SZ 显盈科技301067.SZ 铭科精技001319.SZ 锐新科技300828.SZ 康力源301287.SZ Find similar companies →

Latest newsMore news →

Fengyuan Pharmaceutical's wholly-owned subsidiary Bengbu Fengyuan Tushan Pharmaceutical received drug registration certificates from China's National Medical Products Administration for vonoprazan fumarate tablets (20mg and 10mg).6d ago Fengyuan Pharmaceutical announced that its controlling shareholder Fengyuan Group's concert parties (Anhui Wuwei Pharmaceutical Factory, Ma'anshan Fengyuan Enterprise Management, and Bengbu Tushan Enterprise Management) signed a share transfer agreement with Bengbu Investment Group to transfer 100 million shares (21.53% of total shares) for 641 million yuan, which will change the controlling shareholder to Bengbu Investment Group and the actual controller to Bengbu State-owned Assets Supervision and Administration Commission.20d ago